Form 4 for RKLB Rocket Lab Corp
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-05 · accession 0002001011-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-06 | 2026-01-05 | RKLB | Spice Adam C. | CFO | S - Sale+OE | $75.50 | -1.37M | 2.26M | -38% | -$103.11M |
| D | 2026-01-06 | 2026-01-05 | RKLB | Spice Adam C. | CFO | M - OptEx | $1.09 | +731.3K | 2.73M | +37% | +$797.1K |
| D | 2026-01-06 | 2026-01-05 | RKLB | Spice Adam C. | CFO | M - OptEx | $0.00 | -731.3K | 2.52M | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-05 | S | D | 190,708 | $75.97 | 1,838,148 | D | — | — | (F1) Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F6) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $75.4900 to $76.4850. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2026-01-05 | S | D | 236,951 | $76.99 | 1,601,197 | D | — | — | (F1) Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F7) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $76.5000 to $77.4900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2026-01-05 | S | D | 241,629 | $78.04 | 1,359,568 | D | — | — | (F1) Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F8) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $77.5200 to $78.2400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2026-01-05 | S | D | 234,588 | $74.91 | 2,028,856 | D | — | — | (F1) Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F5) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $74.4900 to $75.4800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2026-01-05 | S | D | 185,066 | $73.03 | 2,515,490 | D | — | — | (F1) Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F3) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $72.4900 to $73.4800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2026-01-05 | S | D | 24,677 | $72.15 | 2,700,556 | D | — | — | (F1) Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F2) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $71.4900 to $72.4800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2026-01-05 | M | A | 731,330 | $1.09 | 2,725,233 | D | — | — | |
| 8 | Common | Common Stock | 2026-01-05 | S | D | 252,046 | $74.02 | 2,263,444 | D | — | — | (F1) Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F4) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $73.4900 to $74.4800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2026-01-05 | M | D | 731,330 | $0.00 | 2,522,825 | D | $1.09 · — to 2028-08-03 | 731,330 Common Stock | (F9) The stock option was granted on August 3, 2018, and had a vesting commencement date of May 25, 2018. 1/4 of the shares subject to the stock option vest on the one year anniversary of the vesting commencement date, and 1/48 of the shares subject to the stock option vest on a monthly basis each month thereafter, subject, in each case, to the reporting person's continued service relationship through each applicable vesting date. |